These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7524871)

  • 1. Treating benign prostatic hyperplasia with medications.
    Long K; Long R
    Nurse Pract Forum; 1994 Sep; 5(3):126-7. PubMed ID: 7524871
    [No Abstract]   [Full Text] [Related]  

  • 2. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the medical management of benign prostatic hyperplasia.
    Jewett MA; Klotz LH;
    CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of benign prostatic hyperplasia.
    Walsh PC
    N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
    [No Abstract]   [Full Text] [Related]  

  • 5. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign prostatic hyperplasia. Age and type of treatment.
    Bono AV; Fava C
    J Urol (Paris); 1995; 101(1):50-2. PubMed ID: 7545731
    [No Abstract]   [Full Text] [Related]  

  • 7. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
    [No Abstract]   [Full Text] [Related]  

  • 9. Benign prostatic hyperplasia (BPH).
    Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the best medical treatment for benign prostate hyperplasia?
    Evans MF; Frank J
    Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical management of benign prostatic hyperplasia.
    Gray M; Allensworth D
    Urol Nurs; 1997 Dec; 17(4):137-41. PubMed ID: 9451241
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign prostatic hyperplasia.
    Doherty AP
    Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of benign prostatic hyperplasia drugs on incidence and pathology grading of prostate cancer].
    Zhu J; Gao JP; Xu AX; Lü XY; Cui L; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):761-3. PubMed ID: 20646494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
    Vahlensieck W
    MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical management of benign prostatic hypertrophy.
    Geller J
    Compr Ther; 1994; 20(12):682-7. PubMed ID: 7533690
    [No Abstract]   [Full Text] [Related]  

  • 17. FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.
    Rich KT; Safranek S
    Am Fam Physician; 2008 Mar; 77(5):665-6. PubMed ID: 18350766
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
    Bredin HC
    Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527
    [No Abstract]   [Full Text] [Related]  

  • 19. Benign prostatic hyperplasia. Medical and minimally invasive treatment options.
    Oesterling JE
    N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494
    [No Abstract]   [Full Text] [Related]  

  • 20. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.